A. Moerman - Concepedia

Author

A. Moerman

University of Arkansas for Medical Sciences ORCID

Also Known As

A M Moerman, A MOERMAN, A Moerman, A. M. Moerman, A. Moerman, A. Moerman-Herzog, ANDREA M. MOERMAN, Andrea M. Moerman-Herzog, Andrea M Moerman-Herzog, Andrea M. Moerman

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of Arkansas for Medical Sciences Central Arkansas Veterans Healthcare System Geriatric Research Education and Clinical Center TuBerculosis Vaccine Initiative Washington University in St. Louis

About

A. Moerman is an author at University of Arkansas for Medical Sciences specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	734
2	Education	4	4	267
3	Natural Sciences	2	2	25
4	Social Sciences	2	2	67
5	Public Health	1	1	35

A. Moerman

Publications

Citations

H-Index

Page 1

	Year	Citations
A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine M.J. Kaashoek, A. Moerman, Josip Madić, Vaccine VaccinationVeterinary VaccineVaccine DevelopmentGlycoprotein E-negative StrainImmunology	1994	170
A long term epidemiological study of bovine viral diarrhoea infections in a large herd of dairy cattle A. Moerman, P. J. Straver, MC de Jong, Veterinary Record VaccinationBvdv Antibody TitresAnimal ScienceVeterinary ScienceTransplacental Bvdv Infections	1993	132
A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves F. A. C. van Engelenburg, M.J. Kaashoek, F.A.M. Rijsewijk, Journal of General Virology	1994	93
Clinical consequences of a bovine virus diarrhoea virus infection in a dairy herd: A longitudinal study A. Moerman, P. J. Straver, M.C.M. de Jong, Veterinary Quarterly Animal ScienceClinical ConsequencesPathogenesisVeterinary SciencePathology	1994	81
Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination Hannah Coleman, William W. Greenfield, Shawna L. Stratton, Cancer Immunology Immunotherapy VaccinationViral LoadCervical CancerVaccine DevelopmentHuman Papillomavirus Vaccines	2016	60
Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants M.J. Kaashoek, F. A. C. van Engelenburg, A. Moerman, Veterinary Microbiology Veterinary VaccineMolecular VirologyPathogenesisImmunologyThymidine Kinase-	1996	51
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with <i>Candida</i> skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3 William W. Greenfield, Shawna L. Stratton, Rebecca S Myrick, OncoImmunology	2015	50
Characterization of a neuronal κB-binding factor distinct from NF-κB A. Moerman, Xianrong Mao, Mandy M Lucas, Molecular Brain Research Molecular PhysiologyMolecular NeuroscienceMedicineImmunologyBrain-immune Interaction	1999	45
Differential Transcriptional Control of the Superoxide Dismutase-2 κB Element in Neurons and Astrocytes Xianrong Mao, A. Moerman, Wei Wang, Journal of Biological Chemistry	2006	39
Chromosome aneuploidy in the spermatozoa of two men with globozoospermia Fréderic Morel, Nathalie Douet‐Guilbert, A. Moerman, Molecular Human Reproduction Dual FishInfertilityFertilityCytogeneticsChromosome Aneuploidy	2004	35

Page 1